No Data
In 2025, US Biotech stocks are expected to rise significantly. jpmorgan's top pick is vertex pharmaceuticals (VRTX.US).
Vertex pharmaceuticals (Vertex) ranked first on the list of US biotechnology stock selections for 2025 released by jpmorgan.
Insider Sale: SVP of $TVTX (TVTX) Sells 12,090 Shares
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Travere Therapeutics (TVTX) Gets a Buy From J.P. Morgan
Express News | Travere Therapeutics Inc : JP Morgan Cuts Target Price to $42 From $43
No Data
No Data
